000 | 02018 a2200553 4500 | ||
---|---|---|---|
005 | 20250516121221.0 | ||
264 | 0 | _c20130912 | |
008 | 201309s 0 0 eng d | ||
022 | _a1469-0691 | ||
024 | 7 |
_a10.1111/1469-0691.12070 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCapone, A | |
245 | 0 | 0 |
_aHigh rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. _h[electronic resource] |
260 |
_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cJan 2013 |
||
300 |
_aE23-E30 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aColistin _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospital Mortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aItaly _xepidemiology |
650 | 0 | 4 |
_aKlebsiella Infections _xdrug therapy |
650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Typing |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
700 | 1 | _aGiannella, M | |
700 | 1 | _aFortini, D | |
700 | 1 | _aGiordano, A | |
700 | 1 | _aMeledandri, M | |
700 | 1 | _aBallardini, M | |
700 | 1 | _aVenditti, M | |
700 | 1 | _aBordi, E | |
700 | 1 | _aCapozzi, D | |
700 | 1 | _aBalice, M P | |
700 | 1 | _aTarasi, A | |
700 | 1 | _aParisi, G | |
700 | 1 | _aLappa, A | |
700 | 1 | _aCarattoli, A | |
700 | 1 | _aPetrosillo, N | |
773 | 0 |
_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 19 _gno. 1 _gp. E23-E30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/1469-0691.12070 _zAvailable from publisher's website |
999 |
_c22249913 _d22249913 |